The Impact of Increasing the Minimum Legal Drinking Age from 18 to 20 Years in Lithuania on All-Cause Mortality in Young Adults-An Interrupted Time-Series Analysis.


Journal

Alcohol and alcoholism (Oxford, Oxfordshire)
ISSN: 1464-3502
Titre abrégé: Alcohol Alcohol
Pays: England
ID NLM: 8310684

Informations de publication

Date de publication:
09 Jul 2022
Historique:
received: 05 04 2021
revised: 22 07 2021
accepted: 30 10 2021
pubmed: 6 12 2021
medline: 14 7 2022
entrez: 5 12 2021
Statut: ppublish

Résumé

To determine the effect of an alcohol policy change, which increased the minimum legal drinking age (MLDA) from 18 years of age to 20 years of age on all-cause mortality rates in young adults (18-19 years old) in Lithuania. An interrupted time series analysis was conducted on a dataset from 2001 to 2019 (n = 228 months). The model tested the effects of the MLDA on all-cause mortality rates (deaths per 100,000 individuals) in three age categories (15-17 years old, 18-19 years old, 20-22 years old) in order to control for general mortality trends in young adults, and to isolate the effects of the MLDA from other alcohol control policies. Additional models that included GDP as a covariate and a taxation policy were tested as well. There was a significant effect of the MLDA on all-cause mortality rates in those 18-19 years old, when modelled alone. Additional analyses controlling for the mortality rate of other age groups showed similar findings. Inclusion of confounding factors (policies on alcohol taxation, GDP) eliminated the effects of MLDA. Although there was a notable decline in all-cause mortality rates among young adults in Lithuania, a direct causal impact of MLDA on all-cause mortality rates in young adults was not definitively found.

Identifiants

pubmed: 34864838
pii: 6438114
doi: 10.1093/alcalc/agab076
pmc: PMC9270988
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

513-519

Subventions

Organisme : NIAAA NIH HHS
ID : R01 AA028224
Pays : United States
Organisme : NIAAA NIH HHS
ID : 1R01AA028224-01
Pays : United States
Organisme : CIHR
ID : SMN-13950
Pays : Canada
Organisme : CMHS SAMHSA HHS
Pays : United States
Organisme : CMHS SAMHSA HHS
Pays : United States
Organisme : CIHR
ID : SMN-13950
Pays : Canada
Organisme : NIAAA NIH HHS
ID : 1R01AA028224-01
Pays : United States

Informations de copyright

© The Author(s) 2021. Medical Council on Alcohol and Oxford University Press. All rights reserved.

Références

J Stud Alcohol Suppl. 2002 Mar;(14):206-25
pubmed: 12022726
Int J Environ Res Public Health. 2020 May 15;17(10):
pubmed: 32429171
Addiction. 2017 Jun;112(6):968-1001
pubmed: 28220587
Alcohol Clin Exp Res. 2005 Feb;29(2):255-62
pubmed: 15714048
Alcohol Alcohol. 2019 Jan 01;54(1):112-118
pubmed: 30260375
Addiction. 2015 Nov;110(11):1757-66
pubmed: 26119584
J Stud Alcohol Drugs. 2018 Jul;79(4):514-522
pubmed: 30079865
Eur Addict Res. 2003 Oct;9(4):157-64
pubmed: 12970584
Inj Prev. 2015 Apr;21(2):77-83
pubmed: 25223238
Addiction. 2020 Apr;115(4):655-665
pubmed: 31475395
Lancet. 2019 Jun 22;393(10190):2493-2502
pubmed: 31076174
Int J Environ Res Public Health. 2021 Mar 02;18(5):
pubmed: 33801260
Traffic Inj Prev. 2015;16(4):345-52
pubmed: 25133786
J Stud Alcohol Drugs Suppl. 2014;75 Suppl 17:108-15
pubmed: 24565317
Alcohol Clin Exp Res. 2019 May;43(5):850-856
pubmed: 30779431
Am J Public Health. 2014 Jun;104(6):1087-91
pubmed: 24825211
Addiction. 2021 Oct;116(10):2673-2684
pubmed: 33751693
Rev Econ Stat. 2015 May;97(2):521-524
pubmed: 26120205
J Econ Perspect. 2011 Spring;25(2):133-56
pubmed: 21595328
Addiction. 2019 Oct;114(10):1866-1884
pubmed: 31058392
Drug Alcohol Rev. 2021 Mar;40(3):350-367
pubmed: 33155370
J Subst Abuse. 1997;9:257-67
pubmed: 9494953
Alcohol Health Res World. 1996;20(4):213-218
pubmed: 31798158

Auteurs

Alexander Tran (A)

Institute for Mental Health Policy Research, Centre for Addiction and Mental Health, 33 Ursula Franklin Street, Toronto, Ontario M5S 2S1, Canada.

Huan Jiang (H)

Institute for Mental Health Policy Research, Centre for Addiction and Mental Health, 33 Ursula Franklin Street, Toronto, Ontario M5S 2S1, Canada.
Dalla Lana School of Public Health, University of Toronto, 155 College Street, Toronto, Ontario M5T 1P8, Canada.

Shannon Lange (S)

Institute for Mental Health Policy Research, Centre for Addiction and Mental Health, 33 Ursula Franklin Street, Toronto, Ontario M5S 2S1, Canada.
Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, 250 College St, Toronto, Ontario M5T 1R8, Canada.

Michael Livingston (M)

Centre for Alcohol Policy Research, Building NR-1, La Trobe University, Plenty Rd. x Kingsbury Rd., Bundoora, Victoria 3086, Australia.
National Drug Research Institute, Health Sciences, Curtin University, Perth, 6102, Australia.
Department of Clinical Neuroscience, Karolinska Institutet, Solnavägen 1, 171 77 Solna, Sweden.

Jakob Manthey (J)

Institute of Clinical Psychology and Psychotherapy, Faculty of Psychologie, Technische Universitat Dresden, Chemnitzer Str. 46, 01187 Dresden, Germany.
Center for Interdisciplinary Addiction Research (ZIS), Department of Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf (UKE), Martinistraße 52, 20246 Hamburg, Germany.
Department of Psychiatry, Medical Faculty, University of Leipzig, Semmelweisstraße 10, 04103 Leipzig, Germany.

Maria Neufeld (M)

Institute for Mental Health Policy Research, Centre for Addiction and Mental Health, 33 Ursula Franklin Street, Toronto, Ontario M5S 2S1, Canada.
Institute of Clinical Psychology and Psychotherapy, Faculty of Psychologie, Technische Universitat Dresden, Chemnitzer Str. 46, 01187 Dresden, Germany.
WHO Regional Office for Europe, Office for Prevention and Control of Noncommunicable Diseases, Moscow, Leontyevsky Pereulok 9, 125009 Moscow, Russian Federation.

Robin Room (R)

Centre for Alcohol Policy Research, Building NR-1, La Trobe University, Plenty Rd. x Kingsbury Rd., Bundoora, Victoria 3086, Australia.
Centre for Social Research on Alcohol and Drugs, Department of Public Health Sciences, Stockholm University, 3rd floor, Sveavägen 160, 113 46 Stockholm, Sweden.

Mindaugas Štelemėkas (M)

Health Research Institute, Faculty of Public Health, Lithuanian University of Health Sciences, Tilžės str. 18, 47181 Kaunas, Lithuania.
Department of Preventive Medicine, Faculty of Public Health, Lithuanian University of Health Sciences, Tilžės str. 18, 47181 Kaunas, Lithuania.

Tadas Telksnys (T)

Health Research Institute, Faculty of Public Health, Lithuanian University of Health Sciences, Tilžės str. 18, 47181 Kaunas, Lithuania.

Janina Petkevičienė (J)

Health Research Institute, Faculty of Public Health, Lithuanian University of Health Sciences, Tilžės str. 18, 47181 Kaunas, Lithuania.
Department of Preventive Medicine, Faculty of Public Health, Lithuanian University of Health Sciences, Tilžės str. 18, 47181 Kaunas, Lithuania.

Ričardas Radišauskas (R)

Department of Environmental and Occupational Medicine, Faculty of Public Health, Lithuanian University of Health Sciences, Tilžės str. 18, 47181 Kaunas, Lithuania.
Institute of Cardiology, Lithuanian University of Health Sciences, Sukilėlių str. 17, 50162 Kaunas, Lithuania.

Jürgen Rehm (J)

Institute for Mental Health Policy Research, Centre for Addiction and Mental Health, 33 Ursula Franklin Street, Toronto, Ontario M5S 2S1, Canada.
Dalla Lana School of Public Health, University of Toronto, 155 College Street, Toronto, Ontario M5T 1P8, Canada.
Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, 250 College St, Toronto, Ontario M5T 1R8, Canada.
Institute of Clinical Psychology and Psychotherapy, Faculty of Psychologie, Technische Universitat Dresden, Chemnitzer Str. 46, 01187 Dresden, Germany.
Center for Interdisciplinary Addiction Research (ZIS), Department of Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf (UKE), Martinistraße 52, 20246 Hamburg, Germany.
World Health Organization/ Pan American Health Organization Collaborating Centre, Centre for Addiction and Mental Health, 33 Ursula Franklin Street, Toronto, Ontario M5S 2S1, Canada.
Faculty of Medicine, Institute of Medical Science, University of Toronto, Medical Sciences Building, 1 King's College Circle, Room 2374, Toronto, Ontario M5S 1A8, Canada.
Department of Psychiatry, University of Toronto, 250 College Street, 8th floor, Toronto, Ontario M5T 1R8, Canada.
Department of International Health Projects, Institute for Leadership and Health Management, .M. Sechenov First Moscow State Medical University, ITrubetskaya str., 8, b. 2, 119992, Moscow, Russian Federation.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH